Relative underweight in cystic fibrosis and its prognostic value.
about
Drug therapies for reducing gastric acidity in people with cystic fibrosisDrug therapies for reducing gastric acidity in people with cystic fibrosisDrug therapies for reducing gastric acidity in people with cystic fibrosisInnate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosisMechanisms of lipid malabsorption in Cystic Fibrosis: the impact of essential fatty acids deficiencyMaintenance of nutritional status in patients with cystic fibrosis: new and emerging therapiesImpact of vitamin D on infectious diseaseCystic fibrosis in AsiansResting energy expenditure and substrate oxidation rates in cystic fibrosis.Pancreatic enzyme replacement therapy in cystic fibrosis: Australian guidelines. Pediatric Gastroenterological Society and the Dietitians Association of Australia.Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional studyIncreasing calorie consumption in children with cystic fibrosis: replication with 2-year follow-upInflammation and cystic fibrosis pulmonary disease.Growth problems and growth hormone treatment in children with cystic fibrosis.Disproportionate head growth retardation in cystic fibrosis.Bone mineral content in cystic fibrosis patients: correlation with fat-free mass.Glycaemic regulation and insulin secretion are abnormal in cystic fibrosis pigs despite sparing of islet cell mass.Relation between insulin-like growth factor-I, body mass index, and clinical status in cystic fibrosis.Nutritional impact of antipseudomonas intravenous antibiotic courses in cystic fibrosisHeight and weight in cystic fibrosis: a cross sectional study. UK Cystic Fibrosis Survey Management Committee.Normal growth in cystic fibrosis associated with a specialised centre.Prospective randomised treatment with recombinant human growth hormone in cystic fibrosisGender differences in habitual activity in children with cystic fibrosis.Nutrient status of adults with cystic fibrosisNutrition in cystic fibrosis: a historical overview.Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project.Percutaneous endoscopic gastrostomy feeding in patients with cystic fibrosis.Heart-lung transplantation for cystic fibrosis. 1: Assessment.Comparison of WHO and CDC growth charts in predicting pulmonary outcomes in cystic fibrosisPancreatic damage in fetal and newborn cystic fibrosis pigs involves the activation of inflammatory and remodeling pathwaysEnteric coated microspheres of pancreatin in the treatment of cystic fibrosis: comparison with a standard enteric coated preparation.Pancreatic and biliary secretion are both altered in cystic fibrosis pigs.Comparing the Use of Centers for Disease Control and Prevention and World Health Organization Growth Charts in Children with Cystic Fibrosis through 2 Years of AgeChanges in Mineral Micronutrient Status During and After Pulmonary Exacerbation in Adults With Cystic Fibrosis.Update on enteral nutrition support for cystic fibrosis.Delayed release pancrelipase for the treatment of pancreatic exocrine insufficiency associated with cystic fibrosis.Cystic fibrosis lung disease in adult patients.Recovery of birth weight z score within 2 years of diagnosis is positively associated with pulmonary status at 6 years of age in children with cystic fibrosis.A novel gene delivery method transduces porcine pancreatic duct epithelial cells.Diagnosing cystic fibrosis-related diabetes: current methods and challenges.
P2860
Q24194860-F0A5475E-05B0-434E-BAB7-DF1D1E7D15F9Q24200289-91C84997-17DD-47B1-ACC2-788F89073F70Q24248758-8B84129D-D149-4ACB-9C86-6879004898A3Q24548775-215FE4DD-7F7F-451A-9F0C-44C521F31021Q24806288-9CE10A0C-68FC-478F-BF45-C3C135CE6400Q26858964-8CB9D0E0-04B9-4537-8165-611E9D61EB80Q27000724-B054EF63-D6AB-4A0B-B069-715E26AAEAD8Q33623081-E7830FF1-30AC-4555-96DB-0F8A1CA4900CQ33623509-4EB09403-AB66-496F-836D-02C2914E3691Q33655567-62EA215D-FBEF-44C2-83A9-5AC44152E311Q33801253-0E889641-738C-40AC-AC76-C2F8203A502AQ34161882-BFF878C1-E38D-4069-9C16-77A6CEFAA1DAQ34249405-56F3AC7D-1BD8-4A69-ADE3-4BFEC777C000Q34716067-7596E4B3-F199-4FF3-AEFF-D3DAC1B74F69Q34795647-AB77C0E2-51E1-478E-ABD0-240D20FA5718Q34798087-71E9F4DC-332F-4E62-B10A-A328CD1B8B8BQ35136628-31AE6679-09B3-4679-85DB-B29211A90B73Q35255110-D55DDD9A-6AA6-4A20-84D5-3BD471960D73Q35255315-5F651D17-736A-4651-8FF9-D0ADF5953F0FQ35257645-4FA2EAED-AFC7-427D-B5F8-DA9306C908BCQ35264856-B2352101-819F-4ECC-8E59-65E82546056DQ35275036-CAB7492B-31F0-4C18-AA22-2CC84098AA53Q35276950-F52E4856-AE63-4841-8C3D-005F41743BBFQ35506608-850BBB79-4D35-46FC-A2E2-0DFF321E28F6Q35531226-48230AE7-3FD2-4514-8AA4-A7048B175C41Q35535262-8AB28900-0A45-4D67-927F-D25372A4D9F8Q35565552-FE9B5058-FDCA-4EE1-A880-A8ECA413B706Q35626650-DD2C4CC6-2356-466C-8C60-F21C9F7864BAQ35749951-C936BF96-DB27-47A2-8EEF-13901EAC7F8FQ36131548-81003C1C-F66D-447A-8E94-B68A5F06CEB4Q36169216-081E66A0-A334-4CE6-8207-553B11672B48Q36312709-8CABE810-CB9A-411F-A278-B19BC1DA816DQ36322491-FAF9D484-6980-448B-A3D5-223612702D6AQ36431188-46888821-6698-4224-ACCF-C07BE426DFD0Q36765322-2B71799D-F033-4263-93A4-29645BDE5D57Q37052832-85993AEB-095B-4008-ACBD-B45675FDF720Q37158336-2CBEAAB5-581F-4C2A-AC62-7B27E38EB596Q37417046-D4E0D405-A1C5-42A4-BE23-58967C5B164CQ37624228-55A804F0-F22F-4CD1-8021-EF335A39DD4BQ38857042-19F86306-38E3-4A2D-8442-DB618EFD9FE0
P2860
Relative underweight in cystic fibrosis and its prognostic value.
description
1978 nî lūn-bûn
@nan
1978 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1978 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
name
Relative underweight in cystic fibrosis and its prognostic value.
@ast
Relative underweight in cystic fibrosis and its prognostic value.
@en
Relative underweight in cystic fibrosis and its prognostic value.
@nl
type
label
Relative underweight in cystic fibrosis and its prognostic value.
@ast
Relative underweight in cystic fibrosis and its prognostic value.
@en
Relative underweight in cystic fibrosis and its prognostic value.
@nl
prefLabel
Relative underweight in cystic fibrosis and its prognostic value.
@ast
Relative underweight in cystic fibrosis and its prognostic value.
@en
Relative underweight in cystic fibrosis and its prognostic value.
@nl
P2093
P2860
P1476
Relative underweight in cystic fibrosis and its prognostic value.
@en
P2093
P2860
P356
10.1111/J.1651-2227.1978.TB16273.X
P577
1978-01-01T00:00:00Z